V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220009807 | 220004024 | 0.76 | 67.6 | null | 2018-12-27 | 2019-01-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 220036512 | CYTARABINE + FLUDARABINE |
| 220009808 | 220004025 | 1.63 | 0 | Curative (C) | 2015-11-16 | 2015-11-16 | DABRAFENIB + TRAMETINIB | 01 | N | 220011125 | ARSENIC TRIOXIDE |
| 220009809 | 220004026 | 1.66 | -1 | Curative (C) | 2015-03-28 | 2015-04-03 | Paclitaxel 7 day | null | null | 220013532 | FLUDARABINE + MELPHALAN |
| 220009810 | 220004027 | 0 | 67 | Disease modification (D) | 2016-02-11 | 2016-02-13 | Cyclophosphamide+Fludara+TBI Allo | 02 | N | 220014565 | MELPHALAN |
| 220009811 | 220004028 | 1.8 | null | Palliative (P) | 2016-01-12 | 2016-01-28 | Fludarabine + Melphalan RIC Allo | Y | N | 220020384 | IPILIMUMAB |
| 220009812 | 220004028 | null | null | null | 2017-04-11 | 2017-04-11 | Arsenic trioxide + Tretinoin | 99 | N | 220020384 | CYCLOPHOSPHAMIDE + FLUDARABINE + MELPHALAN |
| 220009813 | 220004028 | 1.33 | null | null | 2014-05-18 | 2014-07-11 | Triple / Double Intrathecal Therapy | N | null | 220020384 | FEC |
| 220009814 | 220004029 | 1.67 | 114.5 | Not known (9) | null | 2016-07-04 | BEP 3 day | null | null | 220021174 | FEC |
| 220009815 | 220004029 | null | null | Disease modification (D) | 2014-07-16 | 2014-07-30 | CTD (Thalidomide 100mg) | N | N | 220021174 | FBC |
| 220009816 | 220004030 | null | 20.9 | null | null | 2016-04-07 | Cyclophosphamide TBI Allograft | null | N | 220023685 | MITOXANTRONE + TRETINOIN |
| 220009817 | 220004030 | 1.8 | 3.5 | Palliative (P) | 2017-05-25 | 2017-05-25 | Arsenic Triox + Tretinoin Ind W1-4 | 2 | null | 220023685 | MITOXANTRONE |
| 220009818 | 220004030 | 1.55 | 37.7 | Curative (C) | 2019-01-19 | 2019-01-20 | Temozolomide + RT | 2 | N | 220023685 | CYTARABINE + MITOXANTRONE |
| 220009819 | 220004030 | 1.72 | 77.4 | Curative (C) | 2016-11-12 | 2016-11-13 | Bendamustine + prednisolone | N | N | 220023685 | IDARUBICIN |
| 220009820 | 220004031 | null | 75 | Curative (C) | 2018-08-29 | 2018-08-29 | Ipilimumab | 2 | N | 220027990 | ALEMTUZUMAB |
| 220009821 | 220004032 | 1.82 | 95 | Palliative (P) | 2016-12-11 | 2017-11-03 | Cetuximab 7 day (>Cycle 2) | N | N | 220028568 | IPILIMUMAB |
| 220009822 | 220004033 | 1.65 | 77.1 | null | 2012-12-28 | 2013-01-06 | Cisplatin+Fluorouracil+Streptozoc | N | Y | 220029487 | CTD |
| 220009823 | 220004034 | 1.63 | 0 | Curative (C) | 2017-08-03 | 2017-08-03 | ATG + Busulfan + Fludarabine | N | N | 220032071 | FBC |
| 220009824 | 220004035 | null | null | Adjuvant (A) | 2017-06-17 | 2017-06-19 | Cyclophosphamide High Dose | N | N | 220032351 | CAPECITABINE + RT |
| 220009825 | 220004036 | null | null | Palliative (P) | 2016-08-19 | 2016-08-19 | FLUDARABINE | null | null | 220032604 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 220009826 | 220004037 | 1.6 | 42.3 | Palliative (P) | 2016-11-25 | 2016-12-05 | METHOTREXATE | N | N | 220035180 | IPILIMUMAB + NIVOLUMAB |
| 220009827 | 220004038 | 1.65 | 65.7 | null | null | 2017-12-13 | Triple / Double Intrathecal Therapy | N | null | 220035471 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 220009828 | 220004038 | null | null | Palliative (P) | 2018-10-28 | 2018-10-31 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE | N | N | 220035471 | IPILIMUMAB |
| 220009829 | 220004039 | 1.72 | 0 | Curative (C) | 2018-02-09 | 2018-02-09 | Mitoxantrone | Y | N | 220026545 | SPIRIT TRIAL |
| 220009830 | 220004039 | null | 88.6 | Curative (C) | 2015-08-28 | 2015-08-28 | IDARUBICIN | N | N | 220026545 | BUSULPHAN |
| 220009831 | 220004040 | 0 | 0 | Disease modification (D) | 2015-04-02 | 2015-04-02 | Imatinib 400mg | N | N | 220000001 | IMATINIB |
| 220009834 | 220004043 | 0 | null | Disease modification (D) | 2013-12-23 | 2013-12-23 | Imatinib 400mg | 2 | N | 220000022 | IMATINIB |
| 220009835 | 220012143 | 1.83 | 0 | Disease modification (D) | 2015-03-27 | 2015-03-27 | IMATINIB | 2 | N | 220000089 | IMATINIB |
| 220009836 | 220004047 | 0 | 74.3 | Disease modification (D) | 2016-08-30 | 2016-08-30 | IMATINIB | 02 | N | 220000097 | IMATINIB |
| 220009837 | 220004047 | 1.56 | 58 | Disease modification (D) | 2016-04-26 | 2016-04-26 | IMATINIB | N | N | 220000097 | IMATINIB |
| 220009838 | 220004049 | 0 | null | Disease modification (D) | 2013-04-24 | 2013-04-25 | IMATINIB | N | N | 220000120 | IMATINIB |
| 220009839 | 220004052 | null | 0 | Disease modification (D) | 2013-11-11 | 2013-11-14 | IMATINIB | null | null | 220000145 | IMATINIB |
| 220009840 | 220004056 | 0 | 76.4 | Disease modification (D) | 2018-01-25 | 2018-01-25 | IMATINIB | N | N | 220000151 | IMATINIB |
| 220009841 | 220012145 | 1.74 | 96.6 | Disease modification (D) | 2016-04-27 | 2016-04-29 | IMATINIB | N | N | 220000151 | IMATINIB |
| 220009842 | 220012145 | null | 84 | Disease modification (D) | 2018-10-17 | 2018-10-17 | IMATINIB | 2 | N | 220000151 | IMATINIB |
| 220009843 | 220004057 | 1.67 | 0 | Disease modification (D) | 2015-11-11 | 2015-11-13 | IMATINIB | 2 | N | 220000211 | IMATINIB |
| 220009844 | 220004060 | 1.6 | 0 | Disease modification (D) | 2016-11-27 | 2016-11-27 | IMATINIB | N | N | 220000223 | IMATINIB |
| 220009845 | 220004060 | null | 115 | Disease modification (D) | 2016-09-19 | 2016-09-19 | Imatinib 400mg | 2 | N | 220000223 | IMATINIB |
| 220009846 | 220004062 | null | null | Disease modification (D) | 2014-04-29 | 2014-04-29 | IMATINIB | 02 | N | 220000242 | IMATINIB |
| 220009847 | 220004065 | null | 84.2 | Disease modification (D) | 2013-05-14 | 2013-05-15 | IMATINIB | N | N | 220000355 | IMATINIB |
| 220009848 | 220004066 | 1.82 | 0 | Palliative (P) | 2017-04-22 | 2017-06-06 | Imatinib 400mg | N | N | 220000374 | IMATINIB |
| 220009849 | 220004067 | 0 | 0 | Curative (C) | 2013-03-31 | 2014-01-02 | IMATINIB | N | N | 220000374 | IMATINIB |
| 220009850 | 220004067 | null | 154.1 | Palliative (P) | 2017-11-11 | 2017-11-11 | IMATINIB | 02 | N | 220000374 | IMATINIB |
| 220009851 | 220004067 | 0 | 0 | Curative (C) | 2013-09-14 | 2013-09-14 | Imatinib 400mg | 02 | N | 220000374 | IMATINIB |
| 220009852 | 220004068 | 1.73 | 0 | Disease modification (D) | 2017-04-14 | 2017-04-18 | IMATINIB | 02 | N | 220000450 | IMATINIB |
| 220009854 | 220004074 | null | 83.6 | Curative (C) | 2018-04-16 | 2018-04-18 | IMATINIB | 2 | N | 220000538 | IMATINIB |
| 220009855 | 220004075 | 0 | null | Palliative (P) | null | 2013-12-25 | IMATINIB | N | null | 220000633 | IMATINIB |
| 220009856 | 220004077 | 1.77 | 78.2 | null | 2016-06-04 | 2016-11-06 | IMATINIB | 2 | N | 220000633 | IMATINIB |
| 220009857 | 220004079 | 0 | null | Curative (C) | 2014-01-10 | 2014-01-10 | IMATINIB | 99 | null | 220000650 | IMATINIB |
| 220009859 | 220004080 | null | 52.1 | Curative (C) | 2014-01-29 | 2014-01-29 | IMATINIB | 02 | N | 220000676 | IMATINIB |
| 220009862 | 220004082 | 0 | 72 | Curative (C) | 2018-09-03 | 2018-09-06 | IMATINIB | N | N | 220000723 | IMATINIB |